Search

Your search keyword '"Weijian Jiang"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Weijian Jiang" Remove constraint Author: "Weijian Jiang" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
26 results on '"Weijian Jiang"'

Search Results

1. Evaluation of circadian rhythm and prognostic variability pre-and post-CEA or CAS treatment in patients with carotid artery stenosis

2. Differential protection scheme for distribution network with distributed generation based on improved feature mode decomposition and derivative dynamic time warping

3. Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways

4. Fibre-Microbial Curing Tests and Slope Stability Analysis

5. The Importance of Project Description to Charitable Crowdfunding Success: The Mediating Role of Forwarding Times

6. Dexmedetomidine alleviates blood-brain barrier disruption in rats after cerebral ischemia-reperfusion by suppressing JNK and p38 MAPK signaling.

7. Bi-level optimization configuration method for microgrids considering carbon trading and demand response.

8. Supplementary Figure 5 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment

9. Data from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment

10. Supplementary Figure 2 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment

11. Supplementary Figure 3 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment

12. Supplementary Figure 6 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment

13. Supplementary Figure 4 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment

14. Supplementary Figure 1 from Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment

16. Supplementary Figure 4 from PP2A-B55β Antagonizes Cyclin E1 Proteolysis and Promotes Its Dysregulation in Cancer

17. Data from PP2A-B55β Antagonizes Cyclin E1 Proteolysis and Promotes Its Dysregulation in Cancer

18. Supplementary Figure 2 from PP2A-B55β Antagonizes Cyclin E1 Proteolysis and Promotes Its Dysregulation in Cancer

19. Supplementary Figure 6 from PP2A-B55β Antagonizes Cyclin E1 Proteolysis and Promotes Its Dysregulation in Cancer

21. Supplementary Figure 3 from PP2A-B55β Antagonizes Cyclin E1 Proteolysis and Promotes Its Dysregulation in Cancer

22. Supplementary Figure 1 from PP2A-B55β Antagonizes Cyclin E1 Proteolysis and Promotes Its Dysregulation in Cancer

24. Peri-procedural variables and outcomes of long-period hemodynamic instability after carotid artery angioplasty and stenting

26. Study of Mulligan mobilization with movement technique combined with dynamic interference electrotherapy in the treatment of cervical spondylosis

Catalog

Books, media, physical & digital resources